Clinical Trial Update: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic [Phase 3]

View source ↗

Summary

A Phase 3 pragmatic randomized trial compared therapeutic anticoagulation to standard care for COVID-19, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Respiratory Syndrome
• Venous Thromboembolism

Drugs mentioned

• Not specified

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: COVID, Coronavirus Infection | Phase 3 | Status: COMPLETED